Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GeorgeBest
    wrote on sidst redigeret af
    #328

    Thanks E L. What confuse me with 48-60 mg group (91% ORR), if they cut out 60 mg ORR drops, but there is on data on patients only receiving 48 mg? There is a group 12 - 48 mg. Which of cource has lover ORR...

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #329

      Talquetamab may be even more interesting than Teclistamab, because JNJ is first mover in a less crowded market.

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #330

        less crowded target.

        1 Reply Last reply
        0
        • M Offline
          M Offline
          Mcjean
          wrote on sidst redigeret af
          #331

          Hvad med forskellighederne i graden af sygdom, hvor mange behandlinger de to grupper havde op til? noget du har research på eller er det for svært at aflæse udfra data?

          1 Reply Last reply
          0
          • G Offline
            G Offline
            GeorgeBest
            wrote on sidst redigeret af
            #332

            Begge grupper er heavily pretreated

            1 Reply Last reply
            0
            • G Offline
              G Offline
              GeorgeBest
              wrote on sidst redigeret af
              #333

              Jeg ikke læst alle fodnoter, det bliver squ meget langhåret

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #334

                it says that population Includes 3 patients who received 60-mg dose before RP2D was determined. If you look at the charts with tumor changes , it may not actually make that much difference in ORR?

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  GeorgeBest
                  wrote on sidst redigeret af
                  #335

                  Good, but it would have been nice with a group of only 48 mg

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GeorgeBest
                    wrote on sidst redigeret af
                    #336

                    Haven‘t they decided on the optimal dose for Glofitamab? They call it step up dosing...

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #337

                      the scan of that MCL patient on p13 is with only 24mg; I am not a doctor, but that difference after treatment seems pretty clear to me

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        GeorgeBest
                        wrote on sidst redigeret af
                        #338

                        Yes sure

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #339

                          Just a moment...

                          favicon

                          (www.firstwordpharma.com)

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #340

                            Next steps

                            While the burning question was whether or not the novel targets are better used before or after BCMA, the more practical solution is to simply combine the mechanisms. In fact, Johnson & Johnson is already at work on that front, with a Phase I study exploring the combination of talquetamab and the BCMA bispecific antibody teclistamab.

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #341

                              There’s also preclinical data supporting the role of CD38-targeting agents in T-cell expansion, which suggests that front-line therapy Darzelex (daratumumab) could help potentiate the T-cell engaging effect of antibodies like talquetamab. Accordingly, Johnson & Johnson is also evaluating that combination in a Phase I trial- along with various combinations of teclistamab and pomalidomide- which could represent its best opportunity for leapfrogging the BCMA drug class.

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                GeorgeBest
                                wrote on sidst redigeret af
                                #342

                                Tak Sukkeralf. Kombinere T&T må trods alt give ca. 10% til Genmab 😉

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #343

                                  Meget svært pt at gisne om hvorledes MM markedet ser ud 5-10 år ude i fremtiden, men man kan da kun være glad for at Genmabs produkter formentlig vil spille en rolle og at Janssen ikke bare lader stå til !

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #344

                                    En stærk fremtidsvision kunne være hexcd38 i kombi med T&T.

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Plimsoller
                                      wrote on sidst redigeret af
                                      #345

                                      Godt scenarie 🙂

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Plimsoller
                                        wrote on sidst redigeret af
                                        #346

                                        Link Preview Image
                                        Henrykt storbank efter lægemøde: Genmabs aktie kan blive 5750 kr værd

                                        Genmab har fremlagt data på en konference i weekenden, der imponerer analytikerne Genmabs investorer har endnu engang grund til at drømme stort, efter at selskabet i weekenden har fremlagt nye data me

                                        favicon

                                        borsen.dk (borsen.dk)

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #347

                                          Hvad er det for en bank?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger